acetylglucosamine has been researched along with Neurodegenerative Diseases in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JI; Lee, BE; Suh, PG | 1 |
| Aggarwal, A; Cole, RN; Craven, M; Henry, RK; Jacobson, A; Kohr, MJ; Narayanan, B; O'Meally, RN; Reeves, RA; Umapathi, P; Zachara, NE; Zahra, F | 1 |
| Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
| Hanover, JA; Jeong, H; Kim, BG; Kim, HB; Kim, HJ; Kim, HY; Kim, JI; Kwon, T; Lee, BE; Lee, HE; Lee, J; Lee, SE; Myung, K; Suh, PG; Yang, YR; Yi, EC | 1 |
| Bellmann-Strobl, J; Brandt, AU; Chien, C; Demetriou, M; Dennis, JW; Dörr, J; Newton, BL; Paul, F; Pawling, J; Sy, M; Wuerfel, JT; Yu, Z; Zimmermann, HG | 1 |
| Hsieh-Wilson, LC; Sorum, AW; Thompson, JW | 1 |
| Danon, JJ; Davey, AK; Kassiou, M; Mellick, GD; Rudrawar, S; Ryan, P; Xu, M | 1 |
| Nie, H; Yi, W | 1 |
| Bond, MR; Hanover, JA | 1 |
| Huang, J; Sun, C; Wang, M; Wu, B; Xian, H; Yang, Y; Zhao, J; Zheng, Y | 1 |
| Vocadlo, DJ; Yuzwa, SA | 1 |
| Banerjee, PS; Hart, GW; Lagerlöf, O | 1 |
| Chatham, JC; Darley-Usmar, V; McMahon, LL; Wani, WY; Zhang, J | 1 |
| Hsieh-Wilson, LC; Jensen, EH; Rexach, JE; Vinters, HV; Wang, AC | 1 |
| Hanover, JA; Lazarus, BD; Love, DC | 1 |
| Davies, GJ; Martinez-Fleites, C | 1 |
| Hart, GW; Lagerlof, O; Ramirez-Correa, G; Slawson, C | 1 |
| Chertov, AO; Couron, D; Holzhausen, L; Hurley, JB; Kuok, IT; Linton, JD; Parker, E; Sadilek, M; Sweet, IR | 1 |
| Clark, T; Macauley, MS; Shan, X; Skorobogatko, Y; Vocadlo, DJ; Vosseller, K; Yuzwa, SA | 1 |
| Forsythe, ME; Hanover, JA; Krause, MW; Lazarus, BD; Love, DC; Wang, P | 1 |
| Gong, CX; Iqbal, K; Liu, F | 1 |
| Beseme-Dekeyser, O; Dehennaut, V; Guinez, C; Lefebvre, T; Michalski, JC; Morelle, W | 1 |
| Hanover, JA; Love, DC | 1 |
| Gonzalez-Gomez, I; Groffen, J; Heisterkamp, N; Kaartinen, V; Mononen, I | 1 |
| Hart, GW; Zachara, NE | 1 |
13 review(s) available for acetylglucosamine and Neurodegenerative Diseases
| Article | Year |
|---|---|
O-GlcNAcylation in health and neurodegenerative diseases.
Topics: Acetylglucosamine; Aging; Animals; Biomarkers; Brain; Diagnosis, Differential; Disease Susceptibility; Gene Expression Regulation; Glycosylation; Homeostasis; Humans; Neurodegenerative Diseases; Neurons; Protein Processing, Post-Translational | 2021 |
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
O-GlcNAcylation, a sweet link to the pathology of diseases.
Topics: Acetylglucosamine; Animals; Apoptosis; beta-N-Acetylhexosaminidases; Cardiovascular Diseases; Catalysis; Cell Nucleus; Cell Proliferation; Cytoplasm; Diabetes Complications; Diabetes Mellitus, Type 2; Hexosamines; Humans; Insulin; Mitochondria; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Phosphorylation; Protein Processing, Post-Translational; Signal Transduction | 2019 |
O-GlcNAc cycling: a link between metabolism and chronic disease.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Diabetes Mellitus, Type 2; Diet; Energy Metabolism; Gene Expression Regulation; Health Status; Humans; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Protein Processing, Post-Translational; Protein Stability; Uridine Diphosphate N-Acetylglucosamine | 2013 |
O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Topics: Acetylglucosamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antigens, Neoplasm; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases; tau Proteins | 2014 |
Roles of O-GlcNAc in chronic diseases of aging.
Topics: Acetylglucosamine; Aging; Chronic Disease; Diabetes Mellitus; Heart Diseases; Humans; Hyperglycemia; Inflammation; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases | 2016 |
O-GlcNAcylation and neurodegeneration.
Topics: Acetylglucosamine; Acylation; Alzheimer Disease; Animals; beta-N-Acetylhexosaminidases; Brain; Glycoside Hydrolases; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases; Protein Processing, Post-Translational; Proteins | 2017 |
O-GlcNAc cycling: implications for neurodegenerative disorders.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Gene Expression Regulation; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases | 2009 |
GlaxoSmithKline Award Lecture. The O-GlcNAc modification: three-dimensional structure, enzymology and the development of selective inhibitors to probe disease.
Topics: Acetylglucosamine; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases | 2010 |
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
Topics: Acetylglucosamine; Animals; Chronic Disease; Diabetes Mellitus; Glycosylation; Humans; Models, Molecular; Molecular Structure; N-Acetylglucosaminyltransferases; Neoplasms; Neurodegenerative Diseases; Phosphorylation; Protein Conformation; Signal Transduction; Transcription, Genetic | 2011 |
Does O-GlcNAc play a role in neurodegenerative diseases?
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Brain; Glucose; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Nerve Tissue Proteins; Neurodegenerative Diseases; Phosphorylation; Proteasome Endopeptidase Complex; Protein Folding; Protein Processing, Post-Translational; tau Proteins; Vesicular Transport Proteins | 2005 |
The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Caenorhabditis elegans Proteins; Computational Biology; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Mammals; Mice; Mice, Transgenic; Multienzyme Complexes; N-Acetylglucosaminyltransferases; Neoplasm Proteins; Neurodegenerative Diseases; Plant Proteins; Protein Processing, Post-Translational; Signal Transduction; Stress, Physiological; Uridine Diphosphate N-Acetylglucosamine | 2005 |
The emerging significance of O-GlcNAc in cellular regulation.
Topics: Acetylglucosamine; Animals; Cell Physiological Phenomena; Diabetes Mellitus; Glycosylation; Humans; Neurodegenerative Diseases; Phosphorylation; Proteins | 2002 |
12 other study(ies) available for acetylglucosamine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Differential Detection of O-GlcNAcylated proteins in the heart using antibodies.
Topics: Acetylglucosamine; Animals; Antibodies; Contractile Proteins; Heart; Mammals; Mice; Neurodegenerative Diseases; Protein Processing, Post-Translational; Proteome | 2023 |
O-GlcNAcylation regulates dopamine neuron function, survival and degeneration in Parkinson disease.
Topics: Acetylglucosamine; Animals; Behavior, Animal; Cell Survival; Dopaminergic Neurons; Electrophysiological Phenomena; Female; Immunohistochemistry; Male; Mice; Movement Disorders; Neurodegenerative Diseases; Optogenetics; Parkinson Disease; Protein Modification, Translational; Synapses; Up-Regulation | 2020 |
Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration.
Topics: Acetylglucosamine; Adult; Aged; Biomarkers; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; Female; Germany; Humans; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neurodegenerative Diseases; United States | 2021 |
Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.
Topics: Acetylglucosamine; Animals; Brain; Brain Chemistry; Glycosylation; Humans; Memory; Neurodegenerative Diseases; Protein Processing, Post-Translational; Proteome; Proteomics; Tandem Mass Spectrometry | 2018 |
O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease.
Topics: Acetylglucosamine; Animals; Brain; Humans; Neurodegenerative Diseases; Protein Aggregation, Pathological; Protein Folding; Protein Processing, Post-Translational | 2019 |
MADP, a salidroside analog, protects hippocampal neurons from glutamate induced apoptosis.
Topics: Acetylglucosamine; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Survival; Cells, Cultured; Flow Cytometry; Glucosides; Glutamic Acid; Hippocampus; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Phenols; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction | 2014 |
Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration.
Topics: Acetylglucosamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain Mapping; Crosses, Genetic; Female; Glycosylation; Hippocampus; Humans; Inflammation; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases; Neuroglia; Neurons; Phosphorylation; Prosencephalon; Signal Transduction; tau Proteins | 2016 |
Roles of glucose in photoreceptor survival.
Topics: Acetylglucosamine; Adenosine Triphosphate; Animals; Autophagy; Cell Death; Cell Survival; Gas Chromatography-Mass Spectrometry; Glucose; Lactic Acid; Mice; Mice, Inbred C57BL; Mitochondria; NAD; Neurodegenerative Diseases; Neurons; Oxygen Consumption; Photoreceptor Cells, Vertebrate; Retina | 2011 |
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
Topics: Acetylglucosamine; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Animals; Carbohydrate Conformation; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Mice; Mice, Transgenic; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases; Neurons; Phosphorylation; Pyrans; tau Proteins; Thiazoles | 2012 |
O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases.
Topics: Acetylglucosamine; Alleles; Animals; Caenorhabditis elegans; Disease Models, Animal; Humans; Mutation; Neurodegenerative Diseases; Proteolysis | 2012 |
O-GlcNAc cycling modulates neurodegeneration.
Topics: Acetylglucosamine; Animals; Caenorhabditis elegans; Disease Models, Animal; Humans; Mutation; Neurodegenerative Diseases | 2012 |
Progressive neurodegeneration in aspartylglycosaminuria mice.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Central Nervous System; Cytoplasm; Female; Gait; Glial Fibrillary Acidic Protein; Immunoenzyme Techniques; Lysosomal Storage Diseases; Lysosomes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurodegenerative Diseases; Neurons; Urinary Bladder; Vacuoles | 1998 |